Lung development and function in preterm infants in the surfactant treatment era

Annual Review of Physiology

Volumn 62, Issue , 2000, Pages 825-846

  Jobe, A H ^a   Ikegami, M ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Alveolarization; Bronchopulmonary dysplasia; Chronic lung disease; Lung maturation; Respiratory distress syndrome

Indexed keywords

LUNG SURFACTANT;

ARTIFICIAL VENTILATION; CORTICOSTEROID THERAPY; FETUS; FETUS LUNG MATURATION; HUMAN; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG INJURY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PREMATURITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG; PULMONARY SURFACTANTS;

EID: 0033860929     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.62.1.825     Document Type: Review

References (98)

1. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994
2. Developmental and growth of the human lung
3. Alveolar development in the human fetus and infant
4. Human lung growth in late gestation and in the neonate
5. The effects of preterm delivery and mechanical ventilation on human lung growth
6. Formation of pulmonary alveoli and gas-exchange surface area: Quantitation and regulation
7. Temporal-spatial distribution of SP-B and SP-C proteins and mRNAs in developing respiratory epithelium of human lung
8. Ontogeny and effects of exogenous surfactant treatment on SP-A, SP-B, and SP-C mRNA expression in rabbit lungs
9. Surfactant protein C (SP-C) levels in fetal and ventilated preterm rabbit lungs
10. Ontogeny of surfactant protein-A and protein-B in human amniotic fluid as indices of fetal lung maturity
11. Developmental changes of sheep surfactant: In vivo function and in vitro subtype conversion
12. Surfactant inhibition by plasma: Gestational age and surfactant treatment effects in preterm lambs
13. Surfactant metabolism
14. Glucocorticoids and thyroid hormones stimulate biochemical and morphological differentiation of human fetal lung in organ culture
15. Differentiation of type II cells of human fetal lung in vitro
16. Hormonal control of the surfactant system in fetal lung
17. Antenatal corticosteroid therapy: A meta-analysis of the randomized trials - 1972-1974
18. Premature delivery of fetal lambs infused with glucocorticoids
19. Repeated antenatal corticosteroids: Size at birth and subsequent development
20. A retrospective analysis of the effect of antenatal steroid administration on the incidence of respiratory distress syndrome in preterm twin pregnancies
21. The small for gestational age infant: Accelerated or delayed pulmonary maturation? Increased or decreased survival?
22. Neonatal outcome after preterm delivery for preeclampsia
23. Accelerated pulmonary maturation from preterm premature rupture of membranes: A myth
24. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease
25. Acceleration of canalicular development in lungs of fetal mice exposed transplacentally to dexamethasone
26. Minimum interval from fetal betamethasone treatment to postnatal lung responses in preterm lambs
27. Prenatal glucocorticoid and T4 effects on lung morphology in preterm lambs
28. Triamcinolone-induced structural alterations in the development of the lung of the fetal rhesus macaque
29. Long-term effects of betamethasone on fetal development
30. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs
31. Fetal versus maternal and gestational age effects of repetitive antenatal glucocorticoids
32. Corticosteroids and fetal intervention interact to alter lung maturation in preterm lambs
33. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep
34. Effects of low-dose prenatal corticosteroid administration on the premature rat
35. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need
36. Proliferation and differentiation defects during lung development in corticotropin-releasing hormone-deficient mice
37. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation
38. DNA binding of the glucocorticoid receptor is not essential for survival
39. Hormonal regulation of pulmonary surfactant
40. Dexamethasone accelerates postnatal alveolar wall thinning and alters wall composition
41. Developmental and glucocorticoid regulation of surfactant protein mRNAs in fetal sheep
42. Glucocorticoid regulation of surfactant components in immature lambs
43. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor
44. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery
45. Is amniofic fluid analysis the key to preterm labor? A model using interleukin-6 for predicting rapid delivery
46. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition
47. Specific detection of 16 micro-organisms in amniotic fluid by polymerase chain reaction and its correlation with preterm delivery occurrence
48. Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host in fetal, amniotic, and maternal compartments
49. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia
50. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-α interleukin-1β, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia
51. The fetal inflammatory response syndrome
52. Clinical chorioamnionitis and the prognosis for very low birth weight infants
53. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops
54. Amniotic fluid tumor necrosis factor-alpha and the risk of respiratory distress syndrome among preterm infants
55. Necrotizing funisitis: Clinical significance and association with chronic lung disease in premature infants
56. Increased leukocyte elastase of the tracheal aspirate at birth and neonatal pulmonary emphysema
57. Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth
58. Intra-amniotic interleukin-1 alpha treatment alters postnatal adaptation in premature lambs
59. Antenatal intraamniotic endotoxin stimulates lung maturation in preterm sheep
60. Morphometric analysis of the lung in prolonged bronchopulmonary dysplasia
61. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia
62. Pathophysiologic, morphometric, and biochemical studies of the premature baboon with bronchopulmonary dysplasia
63. Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia
64. Chronic lung injury in preterm lambs
65. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis
66. Inflammatory mediators and bronchopulmonary dysplasia
67. Postnatal lung function and morphology in transgenic mice expressing transforming growth factor-alpha
68. Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats
69. Static volume-pressure relations of excised lungs of infants with hyaline membrane disease, newborn and still-born infants
70. Changes in lung volume and deflation stability in hyaline membrane disease
71. Lung volumes and pressure-volume relations of the respiratory system in small ventilated neonates with severe respiratory distress syndrome
72. Corticosteroids and surfactant increase lung volumes and decrease rupture pressures of preterm rabbit lungs
73. Pulmonary surfactant therapy
74. Lung function in premature lambs and rabbits treated with a recombinant SP-C surfactant
75. Immediate improvement in lung volume after exogenous surfactant: Alveolar recruitment versus increased distention
76. Surfactant and mechanical ventilation
77. Ventilator-induced lung injury
78. Chest wall restriction limits high airway pressure-induced lung injury in young rabbits
79. Injurious venfilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung mode
80. High lung inflation increases mRNA levels of EC M components and growth factors in lung parenchyma
81. Tidal ventilation at low airway pressures can augment lung injury
82. Optimizing alveolar expansion prolongs the effectiveness of exogenous suffactant therapy in the adult rabbit
83. Role of neutrophils in lung vascular injury and edema after premature birth in lambs
84. Mechanisms initiating lung injury in the preterm
85. Determinants of the first inspiratory volume and functional residual capacity at birth
86. Physiologic responses to prolonged and slow-rise inflation in the resuscitation of the asphyxiated newborn infant
87. The critical concentration of surfactant in fetal lung liquid at birth
88. Air opening pressure in fetal lungs
89. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs
90. Tidal volume effects on surfactant treatment responses with the initiation of ventilation in preterm lambs
91. Lung lavage of newborns with respiratory distress syndrome
92. Neonatal chronic lung disease
93. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: A possible development basis for the predisposition to chronic lung inflammation in preterm newborns
94. Surfactant protein-A, phosphati-dylcholine, and surfactant inhibitors in epithelial lining fluid - Correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants
95. Surfactant protein-A deficiency in a primate model of bronchopulmonary dysplasia
96. Abnormal surfactant metabolism and function in preterm ventilated baboons
97. Surfactant metabolism in transgenic mice after granulocyte macrophage- colony stimulating factor ablation
98. Interleukin-4 alters surfactant saturated phosphatidylcholine metabolism